J B Chemicals & Pharmaceuticals Ltd

J B Chemicals & Pharmaceuticals Ltd | Sector: Pharmaceuticals | ISIN: INE572A01028

₹ 1,958.95 (0.22%) icon

31 Mar, 2023, 3:29:47 PM
Open
₹ 1,954.75
Prev. Close
₹ 1,954.70
Turnover(lac)
₹ 2,486.44
Day's High
₹ 1,998.00
Day's Low
₹ 1,942.00
52 Wk High
₹ 2,150.00
52 Wk Low
₹ 1,342.20
Book Value
₹ 310.67
Face Value
₹ 2.00
Mkt. Cap (Cr.)
₹ 15,157.88
P/E
39.82
EPS
49.49
Div. Yield
0.84

Stock View

info icon
Edit Image

BUY

Target | 15 Feb, 2023

2,242.39 (13.46%)

J. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical f... Read More

KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 3/31/2023 3:29:47 PM

    ₹ 1958.95 4.25 0.22
  • Open
  • ₹ 1,954.75
  • Prev. Close
  • ₹ 1,954.7
  • Turnover(Lac.)
  • ₹ 2,486
  • Day's High
  • ₹ 1,998
  • Day's Low
  • ₹ 1,942
  • 52 Week's High
  • ₹ 2,150
  • 52 Week's Low
  • ₹ 1,342.2
  • Book Value
  • ₹ 310.67
  • Face Value
  • ₹ 2
  • Mkt Cap (₹ Cr.)
  • 15,157.88
  • P/E
  • 39.82
  • EPS
  • 49.49
  • Divi. Yield
  • 0.84

Corporate Actions

08 Feb , 2023

12:00 AM

Dividend

Dividend amount: 8.5
Announcement date: 08 Feb , 2023

View Details

01 Feb , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

01 Feb , 2023

12:00 AM

14 Dec , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

03 Nov , 2022

12:00 AM

03 Nov , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

05 Jul , 2022

12:00 AM

AGM

Announcement date: 05 Jul , 2022

View Details

26 May , 2022

12:00 AM

Dividend

Dividend amount: 8
Announcement date: 26 May , 2022

View Details

26 Jul , 2022

12:00 AM

26 Jul , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Jun , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 May , 2022

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

28 Jul , 2022

12:00 AM

BookCloser

View Details

SHAREHOLDING SNAPSHOT
01 April , 2023 | 04:02 PM

PROMOTER - TOTAL53.95%

Indian: 0.00%

Foreign: 53.9472%

NON-PROMOTER - TOTAL 46.05%

Institutions: 27.35%

Non-Institutions: 18.71%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

J B Chemicals & Pharmaceuticals Ltd News and Update

Article Image
  • 28 March, 2023 |
  • 4:09 PM

The company supplies its products to 9 out of top 10 global tyre manufacturers and to all of the top 11 tyre, paint, footwear and cosmetics manufacturers in India

Article Image
  • IIFL News Service |
  • 27 March, 2023 |
  • 4:08 PM
Image not found
  • IIFL News Service |
  • 24 March, 2023 |
  • 4:03 PM
ad IconAd Image

FINANCIALS

PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT J B Chemicals & Pharmaceuticals Ltd

  • Padmini Khare Kaicker

  • Non-Exec. & Independent Dir.
  • Sumit Bose

  • Non-Exec. & Independent Dir.
  • Ranjit Shahani.

  • Chairman & Independent Directo
  • Prashant Kumar.

  • Non-Exec & Non-Independent Dir
  • Nikhil Chopra

  • Whole Time Director & CEO
  • GAURAV TREHAN

  • Non-Exec & Non-Independent Dir

Summary

J B Chemicals & Pharmaceuticals (JBC) was originally promoted and incorporated in Maharashtra by J B Mody as J B Mody Chemicals & Pharmaceuticals in December 18th, 1976. The Company is engaged in the business of manufacturing and marketing of diverse range of pharmaceuticals formulations, herbal remedies and APIs. The company has manufacturing units at Thane, Belapur, Ankleshwar, Panoli and Daman. The bulk drug plant at Panoli and formulation plant at Daman became operational in Apr.95. Products like metrogyl, rantac (a ranitidine-based formulation), and nicardia (a cardiac care medicine) form a significant part of the companys sales. JBC has its subsidiaries namely Lekar Healthcare Ltd and J.B Life Science Overseas Ltd. JBC had a tie-up with Justesa Imagen, Spain, to manufacture and market radio diagnostics under the Trazograf brand name. JBC has also diversified into high-growth agro-based products by acquiring McDa Agro (MAL). The products manufactured by MAL complement fertilisers and increase crop productivity. It has entered into a MoU with GNFC to distribute these products locally. The pharmaceutical divisions of Ifiunik Pharmaceuticals and Unique Pharmaceutical Laboratories has been merged into the company with effect from April 2000.Unique Chemicals (A Division of the company) manufacturing and marketing Bulk Drugs has been awarded Certificate of Suitability to Europeon Pharmacopoeia Monograph for Nifedipine EP from Europeon Directorate for the Quality Medicines.In... Read More


Reports by J B Chemicals & Pharmaceuticals Ltd


Reports by J B Chemicals & Pharmaceuticals Ltd